FDA Adverse Event Malfunction Summary report: N

THERASEED PD-103

MDR report key: 6898273 · Received September 27, 2017

Report

Report Number
1037598-2017-00001
Event Type
Malfunction
Date Received
September 27, 2017
Date of Event
April 19, 2017
Report Date
April 25, 2017
Manufacturer
THERAGENICS CORPORATION
Product Code
IWH
UDI-DI
0081378702860
PMA / PMN Number
K010283
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

UPON REVIEW OF THE ORDER FORM, IT WAS CONFIRMED THAT THE UNITS OF ACTIVITY ORDERED BY THE CUSTOMER WAS ENTERED INCORRECTLY DURING THE ORDER ENTRY PROCESS. THE CUSTOMER REQUESTED 1.7 MCI AND THE ORDER WAS ENTERED AS 1.7 U. THE CUSTOMER SERVICE REPRESENTATIVE DID NOT CONFIRM THE ORDER ACTIVITY WITH THE CUSTOMER PRIOR TO ENTRY. THE ACTIVITY WAS ENTERED LOWER THAN REQUESTED BY THE CUSTOMER. THE ERROR WAS NOT DETECTED DURING THE ORDER ENTRY VERIFICATION PROCESS PRIOR TO SHIPMENT OF THE ORDER NOR DURING THE CUSTOMER'S ORDER CONFIRMATION PROCESS. UPON QUALITY REVIEW OF THE RECEIVED ORDER AT THE USERS FACILITY, THE DISCREPANCY WAS DETECTED, AND THE PLANNED TREATMENT WAS CANCELLED. THERE WAS NO FAILURE OR MALFUNCTION. THE SEED ORDER WAS FILLED WITH A LOWER THAN REQUESTED ACTIVITY, WHICH WOULD HAVE RESULTED IN A MISADMINISTRATION.

Description of Event or Problem · 1

SEED ACTIVITY FOR BRACHYTHERAPY ORDER WAS ENTERED USING THE WRONG UNITS CAUSING A DISCREPANCY BETWEEN THE ORDERED SEED STRENGTH AND THE SEED STRENGTH THAT WAS DELIVERED. THE ERROR WAS DETECTED AT THE USER FACILITY PRIOR TO USE AND THE TREATMENT PLAN AND ORDER WAS CANCELLED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
679320 THERASEED PD-103 RADIONUCLIDE BRACHYTHERPY SOURCE IWH THERAGENICS CORPORATION PD-103 1714J 0081378702860

Patients

Seq Age Sex Outcome Treatment
1 60 YR Other